Bendcare Supports aiSLE™ DX Flare Risk Index Testing Access for Patients with Lupus (SLE)
Bendcare Supports aiSLE™ DX Flare Risk Index Testing Access for Patients with Lupus (SLE) News provided by Share this article OKLAHOMA CITY, April 8, 2021 /PRNewswire/ -- Progentec, a leader in diagnostic and digital technologies for the proactive management of autoimmune diseases, announced today that Bendcare, a large healthcare services and technology organization which empowers community rheumatologists in the United States, is supporting clinician and patient access to the aiSLE™ DX Flare Risk Index. Bendcare plans to begin offering rheumatologists in the Bendcare and American Arth...
Source: prnewswire.com